2025 annual financial data
Lexicon Pharmaceuticals 2025 Revenue growth
Direct answer
Revenue growth was 60.24%.
Operating income was -48,911,000 USD and net income was -50,341,000 USD.
Operating cash flow was -67,851,000 USD.
Get free Lexicon Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 49,803,000 USD
- Operating income
- -48,911,000 USD
- Net income
- -50,341,000 USD
- Operating cash flow
- -67,851,000 USD